Zobrazeno 1 - 10
of 68
pro vyhledávání: '"B G, Durie"'
Autor:
D. Roodman, Brian B. G. Durie, Meletios A. Dimopoulos, Evangelos Terpos, Robert A. Kyle, Charalampia Kyriakou, Leonard Bastian, Noopur Raje, Ronald A. Alberico, Jeffrey A. Zonder, Sean Molloy, S. Vincent Rajkumar, Frank D. Vrionis, Sergio Giralt
Publikováno v:
Blood Cancer Journal, Vol 9, Iss 3, Pp 1-10 (2019)
Blood Cancer Journal
Blood Cancer Journal
Multiple myeloma (MM) represents approximately 15% of haematological malignancies and most of the patients present with bone involvement. Focal or diffuse spinal osteolysis may result in significant morbidity by causing painful progressive vertebral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c4472c31ee9048815191d93cb2bcea1
http://link.springer.com/article/10.1038/s41408-019-0187-7
http://link.springer.com/article/10.1038/s41408-019-0187-7
Autor:
P, Sonneveld, B G, Durie, H M, Lokhorst, J P, Marie, G, Solbu, S, Suciu, R, Zittoun, B, Löwenberg, K, Nooter
Publikováno v:
Lancet (London, England). 340(8814)
Resistance to chemotherapy in refractory multiple myeloma is frequently associated with expression of multidrug resistance (MDR). In resistant cells, intracellular accumulation of doxorubicin and vincristine does not occur because the MDR-1 gene prod
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b308a93de15f36b07fa38f5fec05eb99
https://pubmed.ncbi.nlm.nih.gov/8094795
https://pubmed.ncbi.nlm.nih.gov/8094795
Autor:
B G, Durie
Publikováno v:
Hematology/oncology clinics of North America. 6(2)
The last decade has seen major advances in the acquisition of knowledge concerning both the cellular and molecular genetics of multiple myeloma. Although discrete and specific changes associated with the plasma cell disorders have yet to be identifie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::767da498acb0a360d6e578945742563c
https://pubmed.ncbi.nlm.nih.gov/1582985
https://pubmed.ncbi.nlm.nih.gov/1582985
Autor:
B, Van Camp, B G, Durie, C, Spier, M, De Waele, I, Van Riet, E, Vela, Y, Frutiger, L, Richter, T M, Grogan
Publikováno v:
Blood. 76(2)
Bone marrow samples from 55 patients with multiple myeloma (MM) and 23 patients with monoclonal gammopathy of undertermined significance (MGUS) were evaluated with a broad panel of monoclonal antibodies. Plasma cells from 78% (43/55) of patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f8c5f3f101598d129d9357feecb6452a
https://pubmed.ncbi.nlm.nih.gov/1695113
https://pubmed.ncbi.nlm.nih.gov/1695113
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 3(3)
We report the simultaneous expression of T-cell antigens on the myeloma cells from six patients with multiple myeloma (MM). These six patients come from a total population of 215 samples (115 direct samples, clinical incidence of 5.2%) of plasmacytic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::00073b27c6e8bcfa4a525263a1bb86ff
https://pubmed.ncbi.nlm.nih.gov/2194213
https://pubmed.ncbi.nlm.nih.gov/2194213
Publikováno v:
Current topics in microbiology and immunology. 166
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c1e403466891c13aad9c879044e148ee
https://pubmed.ncbi.nlm.nih.gov/2073813
https://pubmed.ncbi.nlm.nih.gov/2073813
Autor:
B G, Durie, E, Vela, V, Baum, A, Leibovitz, C M, Payne, L C, Richter, T M, Grogan, J M, Trent
Publikováno v:
Blood. 66:548-555
Two new human myeloma cell lines have been established from a 36-year- old woman with refractory IgG kappa multiple myeloma in whom bilateral malignant pleural effusions developed. The malignant plasma cells from each effusion were set up in a liquid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca7379d28cc6c14d6669dc8e1ddfefcd
https://doi.org/10.1182/blood.v66.3.548.bloodjournal663548
https://doi.org/10.1182/blood.v66.3.548.bloodjournal663548
Autor:
A C Buzaid, B G Durie
Publikováno v:
Journal of Clinical Oncology. 6:889-905
Management of refractory myeloma represents a common and challenging clinical problem. Approximately 30% to 50% of patients with multiple myeloma do not respond to first-line therapy, and those who initially achieve a remission will eventually relaps
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf8e4a59ca7d20fec6b0804f8353aea0
https://doi.org/10.1200/jco.1988.6.5.889
https://doi.org/10.1200/jco.1988.6.5.889
Publikováno v:
British Journal of Cancer
We have utilized the blast cell assay of Buick et al. (1977) to grow and subsequently cytogenetically analyze cultured colony forming cells (CFUs) from patients with acute and chronic myelogenous leukaemia (AML, CML). Cytogenetic analysis of CFUs was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86e09dc1f1a9d9564cd671e817b243aa
http://europepmc.org/articles/PMC2011249
http://europepmc.org/articles/PMC2011249
Publikováno v:
Blood. 58:471-476
In multiple myeloma, tumor cell mass and labeling index correlate with subsequent survival duration, but do not predict for response to treatment. In the present study was have autoradiographically measured the incorporation of 3H-thymidine as determ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f7d8ab0f1f9655a0d7f6eb12af6d43b
https://doi.org/10.1182/blood.v58.3.471.bloodjournal583471
https://doi.org/10.1182/blood.v58.3.471.bloodjournal583471